Gitte Kronborg - Infectious Diseases

Author Information

Gitte Kronborg is associated with the Department of Infectious Diseases at Hvidovre Hospital, located on Kettegaard Alle 30 in Hvidovre, Denmark. Her research primarily focuses on infectious diseases, with significant contributions to understanding the health dynamics and risks associated with HIV and other infectious conditions.

Research Contributions

Gitte Kronborg has made substantial contributions to the field of infectious diseases, with a particular focus on HIV-related research. Her work includes studies on the risks and health outcomes of individuals living with HIV, such as the incidence of subarachnoid haemorrhages, chronic obstructive pulmonary disease, and tuberculosis. Kronborg has also explored the efficacy and safety of HIV-1 pre-exposure prophylaxis and analyzed health outcomes in the context of severe COVID-19 cases. Her research extends to investigating the incidence of invasive meningococcal disease and the carriage of Streptococcus pneumoniae among specific populations.

Aliases

Gitte Kronborg is also known by the aliases G Kronborg and G. Kronborg. These variations of her name may appear in different publications and citations.

Publication and Citation Metrics

Metric	Count
Total Citations	8676
h-index	47
Paper Count	206

Publications:

Risk of subarachnoid haemorrhages and aneurysms in Danish People Living With HIV, a nationwide cohort study.

DOI: 10.1097/QAD.0000000000003260

Year: 2022

Nonspecific symptoms dominate at first contact to emergency healthcare services among cases with invasive meningococcal disease

DOI: 10.1186/s12875-021-01585-8

Year: 2021

Tuberculosis incidence and mortality in people living with HIV: A Danish nationwide cohort study.

DOI: 10.1016/j.cmi.2021.07.036

Year: 2021

Longer-Term Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide Versus Emtricitabine and Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Week 96 Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

DOI: 10.2139/SSRN.3772801

Year: 2021

Incidence of chronic obstructive pulmonary disease in people with HIV, their parents and siblings in Denmark.

DOI: 10.1093/infdis/jiab369

Year: 2021

Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study

DOI: 10.1186/s12879-021-06745-w

Year: 2021

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.

DOI: 10.1016/S2352-3018(21)00071-0

Year: 2021

High Mortality Among Patients With Severe COVID-19 and Do-not-intubate Orders Despite Use of Remdesivir and Dexamethasone

DOI: 10.21203/rs.3.rs-788108/v1

Year: 2021

Oral and anal carriage of Streptococcus pneumoniae among sexually active men with HIV who have sex with men.

DOI: 10.1093/infdis/jiab512

Year: 2021

Recent increase in incidence of invasive serogroup W meningococcal disease. A retrospective observational study.

DOI: 10.1016/j.ijid.2021.05.086

Year: 2021

How to Choose the Right Insect Repellent?

What Are the Common Types of Infectious Diseases?

What Happens During an Inflammatory Response?

What is Bovine Tuberculosis?

Why is Folate Biosynthesis a Target for Antibiotics?

How is HTS Applied in Infectious Diseases?

What are the Risk Factors for Developing Dengue Hemorrhagic Fever?

How Does the CDC Educate the Public About Infectious Diseases?

What is COVID-19?

What are the Implications of Colonization in Healthcare Settings?

Partnered Content Networks

Relevant Topics